Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.05 USD | +0.50% | +10.72% | -27.47% |
May. 09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.47% | 568M | |
+9.75% | 115B | |
+12.14% | 106B | |
-2.59% | 21.96B | |
-12.40% | 21.87B | |
-5.29% | 19.21B | |
-3.52% | 18.08B | |
-38.57% | 17.71B | |
+6.99% | 14.32B | |
+35.76% | 12.42B |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- Goldman Sachs Downgrades Altimmune to Neutral From Buy, Adjusts Price Target to $6 From $20